Rajiv Ahlawat | NIPER | Mohali

110 Followers

9 SlideShares 110 Followers 88 Folgens

9 SlideShares 110 Followers 88 Folgens

india cochrane isporscniper rajiv ahlawat search strategies rajivahlawats department of pharmacy practice pubmed how to search vaccine pharmacovigilance safety vaccine pharmacovigilance clinical research children new orleans pediatricians respiratory tract infection rti punjab mohali fdc urti pediatrics ispor cost antibiotics pharmacoeconomics niper

Aktivität
Info

Cost analysis of antibiotics utilization in respiratory tract infection using prescribing indicators

Vor 10 Jahren • 680 Aufrufe

Vaccine pharmacovigilance _ rajiv ahlawat

Vor 8 Jahren • 20098 Aufrufe

Cochrane search Strategies_rajivahlawats-ispor sc niper, mohali

Vor 8 Jahren • 244 Aufrufe

Parental education regarding

Vor 11 Jahren • 140 Aufrufe

Respiratory tract infection children-antibiotic use

Vor 11 Jahren • 362 Aufrufe

Yellow fever vaccine safety in healthy indian travellers

Vor 11 Jahren • 332 Aufrufe

Drug utilization review in an outpatient setting children

Vor 11 Jahren • 534 Aufrufe

Utilization of FDC in children respiratory tract infection at an outpatient setting

Vor 11 Jahren • 192 Aufrufe

Costing of drugs for treating reactive airways disease (rad) at a private pediatric outpatient setting in northern india

Vor 10 Jahren • 138 Aufrufe

Smart use of smart phone for the smart clinic - PCNI New Delhi, nov 2016

Gaurav Gupta • Vor 7 Jahren

Agreement between Claims-based and Self-reported Adherence Measures in Patients with Type 2 Diabetes

dylanturner22 • Vor 9 Jahren

Making sense of your own clinic's data

Gaurav Gupta • Vor 8 Jahren

Ipv – need of the hour dr gaurav gupta

Gaurav Gupta • Vor 12 Jahren

india cochrane isporscniper rajiv ahlawat search strategies rajivahlawats department of pharmacy practice pubmed how to search vaccine pharmacovigilance safety vaccine pharmacovigilance clinical research children new orleans pediatricians respiratory tract infection rti punjab mohali fdc urti pediatrics ispor cost antibiotics pharmacoeconomics niper